Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000019617-23-000020
Filing Date
2023-01-05
Accepted
2023-01-05 11:11:03
Documents
1
Confirming Copy
 

Document Format Files

Seq Description Document Type Size
1 FILING JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY JAZZ_PHARMACEUTICALS_PUBLI.htm SC 13G/A 88226
  Complete submission text file 0000019617-23-000020.txt   90174
Mailing Address 383 MADISON AVENUE NEW YORK NY 10017
Business Address 383 MADISON AVENUE NEW YORK NY 10017 2122706000
JPMORGAN CHASE & CO (Filed by) CIK: 0000019617 (see all company filings)

EIN.: 132624428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6021 National Commercial Banks

Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Subject) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-82922
SIC: 2834 Pharmaceutical Preparations